Attached files
| file | filename |
|---|---|
| 8-K/A - 8-K/A - SELLAS Life Sciences Group, Inc. | b86019ae8vkza.htm |
| EX-99.1 - EX-99.1 - SELLAS Life Sciences Group, Inc. | b86019aexv99w1.htm |
| EX-99.2 - EX-99.2 - SELLAS Life Sciences Group, Inc. | b86019aexv99w2.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT AUDITORS
We consent to the incorporation by reference in Registration Statement No. 333-167025 on Form S-3
and Registration Statement Nos. 333-153847 and 333-151154 on Form S-8 of RXi Pharmaceuticals
Corporation (the “Company”) of our report dated April 11, 2011, related to the financial statements
of Apthera, Inc. as of and for the years ended December 31, 2010 and 2009 and for the period from
July 20, 2005 (date of inception) to December 31, 2010, appearing in Item 9.01 of this Current
Report on Form 8-K/A of the Company dated April 14, 2011.
/s/ Lohman Company, PLLC
Mesa, Arizona
April 14, 2011
Mesa, Arizona
April 14, 2011